What is ChromoLogic?
ChromoLogic operates as a multifaceted innovation hub, bridging the gap between advanced biomedical research and industrial security applications. The company's core competency lies in its ability to synthesize complex scientific breakthroughs into actionable, real-world solutions. In the biomedical sphere, ChromoLogic is actively developing next-generation wound care, diagnostic tools, and drug delivery systems, alongside telehealth platforms designed to improve patient outcomes in underserved regions. Simultaneously, the firm addresses critical industrial needs through sophisticated supply chain traceability and security protocols, ensuring the integrity of assets across global logistics networks.
By maintaining a dual-focus strategy, ChromoLogic effectively mitigates market volatility while capitalizing on the convergence of healthcare technology and secure asset management. Their commitment to sustainability and community-centric development distinguishes them from traditional R&D firms, positioning the company as a socially responsible yet highly competitive player in the deep-tech ecosystem.
How much funding has ChromoLogic raised?
ChromoLogic has raised a total of $1.1M across 2 funding rounds:
Debt
$350K
Debt
$756K
Debt (2020): $350K with participation from PPP
Debt (2021): $756K led by PPP
Key Investors in ChromoLogic
PPP
Public-Private Partnership
What's next for ChromoLogic?
With the recent influx of capital, ChromoLogic is poised to transition into a phase of aggressive operational scaling and market penetration. The strategic roadmap likely involves the commercialization of its diagnostic and telehealth pipelines, which are essential for modernizing healthcare delivery. Furthermore, the company is expected to enhance its industrial security offerings, targeting sectors where supply chain transparency is paramount to operational continuity.
Looking ahead, the firm will likely prioritize the integration of its biomedical solutions into broader clinical workflows, while simultaneously expanding its industrial security footprint. This dual-track growth strategy is designed to maximize long-term value, ensuring that ChromoLogic remains at the forefront of technological advancement. As the company continues to execute its mission, stakeholders can anticipate a focus on regulatory milestones and strategic partnerships that will further validate its innovative portfolio in the global marketplace.
